Goldman Sachs

Poppi Founders: Disrupting the Beverage Industry

Implications of an “Americas First” Foreign Policy

Long Gold and Long Stocks

How AI is Driving Drug Discovery: Xaira Therapeutics' Marc Tessier Lavigne

Exceptional organizational success stems from a rigorous commitment to people and clarity of purpose, where high-caliber talent is non-negotiable. Marc Tessier-Lavigne, former president of Stanford and Rockefeller University and current CEO of Xaira Therapeutics, emphasizes that maintaining high standards—such as rejec...

Edward Norton: From Hollywood to High-Impact Entrepreneurship

Will US Stocks Outperform in 2026?

Qatar PM Al Thani: Diplomacy and Qatar's Economic Future

“A Massive Broadening Trade”

Goldman Sachs Chairman and CEO David Solomon on AI, M&A, and Markets

Will macro tailwinds drive stocks higher?

Anastasia Soare: Building a Billion-dollar Beauty Brand

Goldman Sachs Exchanges: Outlook 2026 | Episode 3: Assets and Allocation

Which Equity Markets Will Outperform?

Goldman Sachs Exchanges: Outlook 2026 | Episode 2: Regional Perspectives

Goldman Sachs Exchanges: Outlook 2026 | Episode 1: The Big Picture

Turning $700 into a Billion-Dollar Brand: John Paul DeJoria

Transforming Private Equity Through Employee Ownership: KKR's Pete Stavros

Emerging Markets Could Keep Surging

10,000 Small Businesses: 15 Years of Impact

Oil Market Impacts from Venezuela